- Accueil
- Euronext Bruxelles
- Company regulated news
- Archive
- Company press releases
Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
03 Oct 2024 07:00 CEST |
ION BEAM APPLICATIONS | IBA et l'Institut Jules Bordet piloteront le projet IHI Accelerate.EU pour créer une chaîne de valeur complète pour l'Astate-211 | 20102010 Medical Equipment | Other subject |
03 Oct 2024 07:00 CEST |
ION BEAM APPLICATIONS | IBA and Jules Bordet Institute to lead IHI project Accelerate.EU to create complete Astatine-211 value chain | 20102010 Medical Equipment | Other subject |
02 Oct 2024 18:00 CEST |
OXURION | Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities LLC | 20103010 Biotechnology | Change in Capital |
02 Oct 2024 18:00 CEST |
OXURION | Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC | 20103010 Biotechnology | Change in Capital |
02 Oct 2024 17:47 CEST |
CENERGY | Résultats de l’assemblée générale extraordinaire des actionnaires du 02 Octobre 2024 | 50202010 Electrical Components | General meeting / Board Meeting |
02 Oct 2024 17:46 CEST |
CENERGY | Results of the extraordinary shareholders’ meeting of 2 October 2024 | 50202010 Electrical Components | General meeting / Board Meeting |
02 Oct 2024 14:15 CEST |
NYRSTAR | Nyrstar NV criminal case dismissed by the council chamber of the French-speaking court of first instance in Brussels | 55102050 Nonferrous Metals | Other subject |
02 Oct 2024 14:15 CEST |
NYRSTAR | Nyrstar NV buiten vervolging gesteld door de raadkamer van de Franstalige rechtbank van eerste aanleg te Brussel | 55102050 Nonferrous Metals | Other subject |
02 Oct 2024 08:30 CEST |
SYENSQO | Syensqo - Notification de participation par Norges Bank. | 55101000 Diversified Materials | Change in Capital |
02 Oct 2024 08:30 CEST |
SYENSQO | Syensqo - Participatiemelding van Norges Bank. | 55101000 Diversified Materials | Change in Capital |
02 Oct 2024 08:30 CEST |
SYENSQO | Syensqo - Participation notification by Norges Bank. | 55101000 Diversified Materials | Change in Capital |
01 Oct 2024 18:32 CEST |
SOLVAY | Solvay: verwerving van eigen aandelen en voltooiing van het aandeleninkoopprogramma | 55201000 Chemicals: Diversified | Corporate life |
01 Oct 2024 18:32 CEST |
SOLVAY | Solvay: acquisition of own shares and completion of the share buyback program | 55201000 Chemicals: Diversified | Corporate life |
01 Oct 2024 18:32 CEST |
SOLVAY | Solvay: acquisition d’actions propres et achèvement du programme de rachat d’actions | 55201000 Chemicals: Diversified | Corporate life |
01 Oct 2024 18:19 CEST |
GBL | GBL - Stemrechten en noemer - Situatie op 30 september 2024 | 30202000 Diversified Financial Services | Corporate life |
01 Oct 2024 18:18 CEST |
GBL | GBL - Droits de vote et dénominateur - Situation au 30 septembre 2024 | 30202000 Diversified Financial Services | Corporate life |
01 Oct 2024 18:17 CEST |
GBL | GBL - Voting rights and denominator - Situation as at September 30, 2024 | 30202000 Diversified Financial Services | Corporate life |
01 Oct 2024 18:00 CEST |
ION BEAM APPLICATIONS | IBA - Regulated Information | 20102010 Medical Equipment | Legal |
01 Oct 2024 18:00 CEST |
ION BEAM APPLICATIONS | IBA SA – NOTIFICATION TRANSPARENCE | 20102010 Medical Equipment | Legal |
01 Oct 2024 08:35 CEST |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
01 Oct 2024 08:33 CEST |
TITAN CEMENT | Share buyback programme | 50101030 Cement | Other subject |
01 Oct 2024 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Buy back of own shares – week from 23/09/2024 to 27/09/2024 | 30202010 Asset Managers and Custodians | Other subject |
01 Oct 2024 08:30 CEST |
SYENSQO | Syensqo - Notification de participation par BlackRock Inc. | 55101000 Diversified Materials | Change in Capital |
01 Oct 2024 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage : Rachat d’actions propres – semaine du 23/09/2024 au 27/09/2024 | 30202010 Asset Managers and Custodians | Other subject |
01 Oct 2024 08:30 CEST |
SYENSQO | Syensqo - Participatiemelding van BlackRock Inc. | 55101000 Diversified Materials | Change in Capital |
01 Oct 2024 08:30 CEST |
SYENSQO | Syensqo - Participation notification by BlackRock Inc. | 55101000 Diversified Materials | Change in Capital |
01 Oct 2024 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 23/09/2024 tot 27/09/2024 | 30202010 Asset Managers and Custodians | Other subject |
01 Oct 2024 07:00 CEST |
BIOTALYS NV | Biotalys Expands R&D Pipeline with New Biofungicide Program | 55201015 Fertilizers | - |
01 Oct 2024 07:00 CEST |
VGP | VGP NV: Voting Rights and Denominator | 35101010 Real Estate Holding and Development | Change in Capital |
01 Oct 2024 07:00 CEST |
VGP | VGP NV: Stemrechten en Noemer | 35101010 Real Estate Holding and Development | Change in Capital |
30 Sep 2024 23:00 CEST |
ONTEX GROUP | Ontex bereikt belangrijke mijlpaal in herschikking van activiteiten-portefeuille, met bindende overeenkomst om Braziliaanse bedrijfsactiviteiten aan Softys te verkopen | 45201020 Personal Products | Mergers, Acquiqitions, Transferts |
30 Sep 2024 23:00 CEST |
ONTEX GROUP | Ontex reaches important milestone in reshaping its portfolio with binding agreement to sell its Brazilian business to Softys | 45201020 Personal Products | Mergers, Acquiqitions, Transferts |
30 Sep 2024 18:11 CEST |
GBL | GBL - Transacties op GBL-aandelen 30-09-2024 | 30202000 Diversified Financial Services | Other financial transaction |
30 Sep 2024 18:11 CEST |
GBL | GBL - Transactions sur actions propres 30-09-2024 | 30202000 Diversified Financial Services | Other financial transaction |
30 Sep 2024 18:10 CEST |
GBL | GBL - Transactions on GBL shares 30-09-2024 | 30202000 Diversified Financial Services | Other financial transaction |
30 Sep 2024 18:02 CEST |
FLUXYS BELGIUM | Fluxys Belgium: Informations réglementées - Résultats du premier semestre 2024 | 60101035 Pipelines | Commercial results |
30 Sep 2024 18:02 CEST |
FLUXYS BELGIUM | Fluxys Belgium: Gereglementeerde informatie - Resultaten eerste semester 2024 | 60101035 Pipelines | Commercial results |
30 Sep 2024 18:02 CEST |
FLUXYS BELGIUM | Fluxys Belgium: Regulated information - Results for the first half of 2024 | 60101035 Pipelines | Commercial results |
30 Sep 2024 18:00 CEST |
OXURION | Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie | 20103010 Biotechnology | Change in Capital |
30 Sep 2024 18:00 CEST |
OXURION | Oxurion publie ses résultats du premier semestre 2024 | 20103010 Biotechnology | Sales, Income |
30 Sep 2024 18:00 CEST |
OXURION | Oxurion Publishes First Half 2024 Results | 20103010 Biotechnology | Sales, Income |
30 Sep 2024 18:00 CEST |
OXURION | Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas | 20103010 Biotechnology | Change in Capital |
30 Sep 2024 17:47 CEST |
CENERGY | Cenergy Holdings fait état de l'avancement de son programme de rachat d'actions propres | 50202010 Electrical Components | Share introduction and issues |
30 Sep 2024 17:46 CEST |
CENERGY | Cenergy Holdings reports on the progress of its Share Buyback Program | 50202010 Electrical Components | Share introduction and issues |
30 Sep 2024 17:45 CEST |
WAREHOUSES ESTATES BELGIUM - W.E.B. | WEB SA - STATUTORY HALF-YEAR RESULTS AS AT 30/06/2024 | 35102030 Office REITs | Other subject |
30 Sep 2024 17:45 CEST |
WAREHOUSES ESTATES BELGIUM - W.E.B. | WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2024 | 35102030 Office REITs | Other subject |
30 Sep 2024 17:40 CEST |
AGEAS | Ageas rapporteert over de inkoop van eigen aandelen | 30301010 Life Insurance | Other financial transaction |
30 Sep 2024 17:40 CEST |
AGEAS | Ageas reports on the progress of share buy-back programme | 30301010 Life Insurance | Other financial transaction |
30 Sep 2024 17:40 CEST |
AGEAS | Rapport d’Ageas sur le programme de rachat d’actions | 30301010 Life Insurance | Other financial transaction |
30 Sep 2024 08:05 CEST |
BIOSENIC | BioSenic announces that it has started to look for new assets, the securing of its financing for the coming months by means of an amendment to its convertible bond contract, a change to the composition of its board of directors | 20103010 Biotechnology | Corporate life |